Imunon Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Imunon Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- IMNN
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000749647
Board of directors
-
Christine A. Pellizzari · DirectorSince 2023
-
Donald P. Braun · DirectorSince 2023
-
Frederick J. Fritz · DirectorSince 2023
-
Goff Corinne Le · Director · President and CEOSince 2023
-
James E. Dentzer · DirectorSince 2023
-
Michael H. Tardugno · Director · Executive Chairman of BoardSince 2023
-
Pok Yu Augustine Chow · DirectorSince 2023
-
Stacy Lindborg · Director · President and CEOSince 2023
Chief executives
Goff Corinne Le
· President and CEO
Dates unknown
Stacy Lindborg
· President and CEO
Dates unknown
Board connections
2 of this board's directors also sit on 3 other boards.
- via James E. Dentzer
- via Christine A. Pellizzari
- via Christine A. Pellizzari
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $30,187
- 4 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 3, 2026 | Eylward Susan Officer (General Counsel and Corp Sec) | Open-market sale | −2,541 | $1.57 | $3,977 |
| Jul 31, 2026 | Donald P. Braun Director | Grant or award | +6,180 | $1.59 | $9,826 |
| Jul 31, 2026 | James E. Dentzer Director | Grant or award | +6,934 | $1.59 | $11,025 |
| Jul 31, 2026 | Eylward Susan Officer (General Counsel and Corp Sec) | Grant or award | +2,541 | $1.59 | $4,040 |
| Jul 31, 2026 | Faller Douglas Vincent Officer (Chief Medical Officer) | Grant or award | +3,649 | $1.59 | $5,802 |
| Jul 31, 2026 | Frederick J. Fritz Director | Grant or award | +6,934 | $1.59 | $11,025 |
| Jul 31, 2026 | Stacy Lindborg Director, Officer (President and CEO) | Grant or award | +5,010 | $1.59 | $7,966 |
| Jul 31, 2026 | Michael H. Tardugno Director, Officer (Executive Chairman of Board) | Grant or award | +6,358 | $1.59 | $10,109 |
| Jul 31, 2026 | Christine A. Pellizzari Director | Grant or award | +6,934 | $1.59 | $11,025 |
| Jul 20, 2026 | Eylward Susan Officer (General Counsel and Corp Sec) | Open-market sale | −2,150 | $1.78 | $3,830 |
| Jul 17, 2026 | Eylward Susan Officer (General Counsel and Corp Sec) | Grant or award | +2,150 | $1.83 | $3,935 |
| Jul 17, 2026 | Faller Douglas Vincent Officer (Chief Medical Officer) | Grant or award | +3,082 | $1.83 | $5,640 |
| Jul 17, 2026 | Stacy Lindborg Director, Officer (President and CEO) | Grant or award | +4,907 | $1.83 | $8,980 |
| Jul 17, 2026 | Michael H. Tardugno Director, Officer (Executive Chairman of Board) | Grant or award | +4,603 | $1.83 | $8,423 |
| Jul 6, 2026 | Eylward Susan Officer (General Counsel and Corp Sec) | Open-market sale | −920 | $1.88 | $1,730 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.